Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observations.

Schwartsmann, G

Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observations. [electronic resource] - Leukemia Mar 1997 - S28-31 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0887-6924


Adult
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Azacitidine--administration & dosage
Bone Marrow--drug effects
Daunorubicin--administration & dosage
Decitabine
Drug Administration Schedule
Female
Humans
Immunophenotyping
Infusions, Intravenous
Karyotyping
Leukemia, Myeloid, Acute--drug therapy
Male
Middle Aged